In PCD patients, compared to controls, the CDR2L gene was more likely to be upregulated, mutated, and expressed at a protein level while CDR2 was differentially expressed and mutated while no significant changes were noted at a protein expression level [27,28]. This evidence concerns the gene CDR2L and paraneoplastic neurologic syndrome.